Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

Psychosomatics

Volumn 43, Issue 6, 2002, Pages 451-455

  Masand, Prakash S ^a,b,c   Gupta, Sanjay ^a,b,c   Schwartz, Thomas L ^a,b,c   Kaplan, David ^a,b,c   Virk, Subhdeep ^a,b,c   Hameed, Ahmad ^a,b,c   Lockwood, Kari ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; DIARRHEA; DOSE RESPONSE; FEMALE; GASTROENTEROLOGY; HUMAN; IRRITABLE COLON; MALE; PREDICTION; STOMACH EMPTYING;

EID: 0036840750     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.43.6.451     Document Type: Article

References (37)

1. Kumar D, Thompson PD, Wingate DL, Vesselinova-Jenkins CK, Libby G: Abnormal REM sleep in the irritable bowel syndrome. Gastroenterology 1992; 103:12-17
2. Triadafilopoulos G, Simms RW, Goldenberg DL: Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991; 36:59-64
3. Fass R, Fullerton S, Naliboff B, Hirsh T, Mayer EA: Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion 1998; 59:79-85
4. Mayer EA: Emerging disease model for functional gastrointestinal disorders. Am J Med 1999; 107:12S-19S
5. Drossman DA: Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999; 107(5A):41S-50S
6. Blanchard EB, Scharff L, Schwarz SP, Suls JM, Barlow DH: The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990; 28:401-405
7. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G: Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease. Am J Psychiatry 1990; 147:1656-1661
8. Lydiard RB, Fossey MD, Marsh W, Ballenger JC: Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993; 34:229-234
9. Walker EA, Katon WJ, Roy-Byrne PP, Jemelka RP, Russo J: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993; 150:1502-1506
10. Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W: Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry 1996; 57:576-578
11. Blewett A, Allison M, Calcraft B, Moore R, Jenkins P, Sullivan G: Psychiatric disorder and outcome in irritable bowel syndrome. Psychosomatics 1996; 37:155-160
12. Lydiard RB, Laraia MT, Howell EF, Ballenger JC: Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986; 47:470-473
13. Noyes R Jr, Cook B, Garvey M, Summers R: Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990; 31:75-79
14. Tollefson GD, Tollefson SL, Pederson M, Luxenberg M, Dunsmore G: Comorbid irritable bowel syndrome in patients with generalized anxiety disorder and major depression. Ann Clin Psychiatry 1991; 3:215-222
15. Kaplan D, Masand PS, Gupta S: The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry 1996; 8:81-88
16. Masand PS, Sousou AJ, Gupta S, Kaplan DS: Irritable bowel syndrome (IBS) and alcohol abuse or dependence. Am J Drug Alcohol Abuse 1998; 24:513-521
17. Drossman DA, Sandler RS, McKee DC, Lovitz AJ: Bowel patterns among subjects not seeking health care: Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83:529-534
18. Mayer EA, Raybould HE: Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99:1688-1704
19. Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, Walker E: Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 1996; 91:906-913
20. Somers VK, Dyken ME, Mark AL, Abboud FM: Sympatheticnerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303-307
21. Tollefson GD, Luxenberg M, Valentine R, Dunsmore G, Tollefson SL: An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. J Clin Psychiatry 1991; 52:502-508
22. Read NW, Gwee K-A: The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 1994; 62:159-173
23. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder: A randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167:374-379
24. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I: Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA 1998; 280:708-713
25. Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L: Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997; 95:444-450
26. Zohar J, Judge R (OCD Paroxetine Study Investigators): Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry 1996; 169:468-474
27. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G: Functional bowel disease and functional abdominal pain. Gastroenterology Int 1992; 5:75-91
28. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU Side Effect Rating Scale: A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334:1-100
29. Kobak KA, Taylor LH, Dottl SL, Greist JH, Jefferson JW, Burroughs D, Mantle JM, Katzelnick DJ, Norton R, Henk HJ, Serlin RC: A computer-administered telephone interview to identify mental disorders. JAMA 1997; 278:905-910
30. Mundt JC, Kobak KA, Taylor LV, Mantle JM, Jefferson JW, Katzelnick DJ, Greist JH: Administration of the Hamilton Depression Rating Scale using interactive voice response technology. MD Comput 1998; 15:31-39
31. Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ: Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput 1999; 16:64-68
32. Baer L, Jacobs DG, Cukor P, O'Laughlen J, Coyle JT, Magruder KM: Automated telephone screening survey for depression. JAMA 1995; 273:1943-1944
33. Myren J, Groth H, Larssen SE, Larsen S: The effect of trimipramine in patients with the irritable bowel syndrome: A double-blind study. Scand J Gastroenterol 1982; 17:871-875
34. Myren J, Lovland B, Larssen SE, Larsen S: Psychopharmacologic drugs in the treatment of the irritable bowel syndrome: A double blind study of the effect of trimipramine. Ann Gastroenterol Hepatol 1984; 20:117-123
35. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K: Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med 2000; 108:65-72
36. Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with irritable bowel syndrome: A five-year clinical experience. Aliment Pharmacol Ther 1994; 8:409-416
37. Fishbain D: Evidence-based data on pain relief with antidepressants. Ann Med 2000; 32:305-316